Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness
This study has been completed.
Study NCT01124851   Information provided by Abbott

First Received on April 26, 2010.   Last Updated on June 30, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sleep Disorder
Additional conditions recognized in this trial
Parasomnias
Sleep Disorders
More general conditions related to this trial
Mental Disorders
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
ABT-652
Placebo
Sponsors listed in this trial
Abbott


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services